Trends in biotech literature 2009
نویسندگان
چکیده
منابع مشابه
Biotech Funding Trends
This is a must-have resource for biotech entrepreneurs and investors, as well as invaluable supplementary reading for students aspiring to a career in the industry. In particular, it illustrates the tensions between both sides based on their different backgrounds and expectations. The book outlines the various funding opportunities for the biotech industry in Europe and identifies ways for both...
متن کاملBiotech Funding Trends
This is a must-have resource for biotech entrepreneurs and investors, as well as invaluable supplementary reading for students aspiring to a career in the industry. In particular, it illustrates the tensions between both sides based on their different backgrounds and expectations. The book outlines the various funding opportunities for the biotech industry in Europe and identifies ways for both...
متن کاملBiotech Funding Trends
This is a must-have resource for biotech entrepreneurs and investors, as well as invaluable supplementary reading for students aspiring to a career in the industry. In particular, it illustrates the tensions between both sides based on their different backgrounds and expectations. The book outlines the various funding opportunities for the biotech industry in Europe and identifies ways for both...
متن کاملBiotech Funding Trends
This is a must-have resource for biotech entrepreneurs and investors, as well as invaluable supplementary reading for students aspiring to a career in the industry. In particular, it illustrates the tensions between both sides based on their different backgrounds and expectations. The book outlines the various funding opportunities for the biotech industry in Europe and identifies ways for both...
متن کاملEmerging Trends in Biotech/Pharmaceutical Collaborations
This decline can be attributed primarily to a more cautious regulatory climate caused by recent highprofile safety issues. 3 As a result of the heightened bar to obtain FDA approval, the life sciences sector has been plagued by a dearth of new product flow. All players in the industry—even large pharmaceutical companies—have been affected. Notably, only Novartis and GlaxoSmithKline (GSK) releas...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Biotechnology
سال: 2010
ISSN: 1087-0156,1546-1696
DOI: 10.1038/nbt0910-887